Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Gross Profit (2019 - 2025)

Volitionrx's Gross Profit history spans 7 years, with the latest figure at -$639296.0 for Q4 2025.

  • For Q4 2025, Gross Profit rose 39.69% year-over-year to -$639296.0; the TTM value through Dec 2025 reached -$2.4 million, up 44.26%, while the annual FY2025 figure was -$2.6 million, 35.98% up from the prior year.
  • Gross Profit reached -$639296.0 in Q4 2025 per VNRX's latest filing, down from -$420186.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of -$401871.0 in Q1 2021 to a low of -$1.8 million in Q4 2021.
  • Average Gross Profit over 5 years is -$1.1 million, with a median of -$1.3 million recorded in 2023.
  • Peak YoY movement for Gross Profit: tumbled 443.25% in 2021, then surged 58.71% in 2024.
  • A 5-year view of Gross Profit shows it stood at -$1.8 million in 2021, then rose by 13.56% to -$1.6 million in 2022, then decreased by 6.19% to -$1.7 million in 2023, then soared by 35.95% to -$1.1 million in 2024, then soared by 39.69% to -$639296.0 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Gross Profit are -$639296.0 (Q4 2025), -$420186.0 (Q3 2025), and -$636846.0 (Q2 2025).